Daniel J. O'Connor - 01 Jan 2023 Form 3 Insider Report for Ambrx Biopharma Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AMAM	Employee Stock Stock Option (right to buy)							01 Jan 2023	Ordinary Shares	5,410,000	$0.1300	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Twenty-five percent of the Ordinary Shares subject to the option vests on November 1, 2023, and the remainder vests in thirty-six equal monthly installments following such date.
F2	The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.